Intelligent Bio Solutions (INBS) EBIT Margin Growth (1y) (2020 - 2025)

Intelligent Bio Solutions (INBS) EBIT Margin Growth (1y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn -430.00
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 128.00
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -361.00
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn 102.00
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn 851.00
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn -313.00
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 241.00
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn 535.00
10 Intelligent Bio Solutions 12.89 Mn 11.69 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 727.00
Dec 31, 2024 -11,213.00
Sep 30, 2024 492.00
Mar 31, 2024 107,308.00
Dec 31, 2023 33,682.00
Sep 30, 2023 3,328.00
Jun 30, 2023 -43,497.00
Mar 31, 2023 -73,406.00
Dec 31, 2022 135,239.00
Jun 30, 2022 2,678.00
Mar 31, 2022 846,112.00
Dec 31, 2021 -162,574.00
Jun 30, 2021 -460,711.00
Mar 31, 2021 -727,846.00
Dec 31, 2020 21.32 Mn